Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
28,000
Employees28,000
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
28,000
Employees28,000

AMGN Key Statistics

Market cap
158.61B
Market cap158.61B
Price-Earnings ratio
24.10
Price-Earnings ratio24.10
Dividend yield
3.19%
Dividend yield3.19%
Average volume
2.58M
Average volume2.58M
High today
$297.63
High today$297.63
Low today
$292.29
Low today$292.29
Open price
$295.79
Open price$295.79
Volume
2.91M
Volume2.91M
52 Week high
$335.88
52 Week high$335.88
52 Week low
$253.30
52 Week low$253.30

AMGN News

TipRanks 3d
Amgen Stock Falls as It Cuts 60% Off Cholesterol Drug Price, Heeding Trump’s Clamor

Top American pharmaceutical firm Amgen (AMGN) on Monday cut the ribbon on AmgenNow, its new direct-to-consumer platform. It kicked off the launch with a 60% dis...

Benzinga 3d
Amgen To Offer Cholesterol Drug At 60% Discount - Amgen - Benzinga

...

Amgen To Offer Cholesterol Drug At 60% Discount - Amgen - Benzinga
Benzinga 3d
Amgen To Offer Cholesterol Drug At 60% Discount As Trump Administration's Call To Lower Drug Prices

Amgen Inc. (NASDAQ:AMGN) on Monday launched AmgenNow, a new direct-to-patient program starting with Repatha (evolucumab). AMGN stock is trending lower. View th...

Amgen To Offer Cholesterol Drug At 60% Discount As Trump Administration's Call To Lower Drug Prices

Analyst ratings

48%

of 33 ratings
Buy
42.4%
Hold
48.5%
Sell
9.1%

More AMGN News

Seeking Alpha 3d
Amgen to offer Repatha at 60% discount to U.S. consumers

Amgen (NASDAQ:AMGN) said on Monday that it has launched its cholesterol medication, Repatha, directly to consumers in the U.S. at a reduced cash price. This mo...

Amgen to offer Repatha at 60% discount to U.S. consumers
TipRanks 3d
Amgen makes Repatha available through ‘AmgenNow’ direct to patient program

Amgen (AMGN) announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha. This follows landmark results demonstrating Repatha signif...

Simply Wall St 5d
A Look at Amgen Valuation Following Landmark Repatha Trial Results and Newly Approved Indications

Amgen (AMGN) is getting well-deserved attention after announcing that its Phase 3 VESALIUS-CV trial for Repatha hit its dual primary endpoints. The study showed...

A Look at Amgen Valuation Following Landmark Repatha Trial Results and Newly Approved Indications

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.